Cargando…
Therapeutic Peptide Nucleic Acids: Principles, Limitations, and Opportunities
Since their invention in 1991, peptide nucleic acids (PNAs) have been used in a myriad of chemical and biological assays. More recently, peptide nucleic acids have also been demonstrated to hold great potential as therapeutic agents because of their physiological stability, affinity for target nucle...
Autores principales: | Quijano, Elias, Bahal, Raman, Ricciardi, Adele, Saltzman, W. Mark, Glazer, Peter M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
YJBM
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733847/ https://www.ncbi.nlm.nih.gov/pubmed/29259523 |
Ejemplares similares
-
Nanoparticle‐mediated genome editing in single‐cell embryos via peptide nucleic acids
por: Putman, Rachael, et al.
Publicado: (2022) -
Peptide Nucleic Acids as a Tool for Site-Specific Gene Editing
por: Ricciardi, Adele S., et al.
Publicado: (2018) -
Peptide Nucleic Acids and Gene Editing: Perspectives on Structure and Repair
por: Economos, Nicholas G., et al.
Publicado: (2020) -
DNA recognition and induced genome modification by a hydroxymethyl-γ tail-clamp peptide nucleic acid
por: Oyaghire, Stanley N., et al.
Publicado: (2023) -
Extracellular vesicles mediated exocytosis of antisense peptide nucleic acids
por: Malik, Shipra, et al.
Publicado: (2021)